Anatomic suitability for transapical transcatheter mitral valve implantation using a tether‐based device
Catheterization and Cardiovascular Interventions · 2023-08 · 102 (2) · 318-327
DOI: 10.1002/ccd.30752 ↗At a glance
Journal article in Catheterization and Cardiovascular Interventions, published online on 2023-06-24. Written by Philipp Blanke and 6 co-authors. Institution: St. Paul's Hospital and University of British Columbia, Vancouver, British Columbia, Canada. Major MEDLINE topics: Mitral Valve Insufficiency, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis. Cited 3 times so far (Crossref); 10 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Background
Transcatheter mitral valve implantation (TMVI) is a novel therapeutic option for treating symptomatic mitral valve disease. Evaluating patient anatomical suitability is a critical step in the TMVI screening process, but currently requires specialized software and computerized device models.
Aims
This analysis sought to assess the effectiveness of simple and standardized multislice computed tomography (MSCT) anatomic measurements for their ability to discriminate between patients who passed anatomical screening for Tendyne™ TMVI.
Methods
Subjects screened for the Tendyne Expanded Clinical Study from January 2016 through September 2019 were included. Core laboratory screening measurements included mitral annular (MA) dimensions at end‐systole and end‐diastole, simulated device implantation, and neo‐left ventricular outflow tract (LVOT) area. Additionally, nine standard measurements of patient anatomy were assessed for their predictive value of patients passing the anatomic screening process.
Results
Out of 496 subjects screened for eligibility, 257 subjects met clinical eligibility criteria with MA dimensions within the manufacturer's suggested range: 153 (59.5%) underwent TMVI while 104 (40.5%) were excluded from the study for other anatomic reasons (76% due to risk of LVOT obstruction). CT‐derived left ventricular end‐systole diameter (LVESD) had the highest discriminatory power for predicting TMVI anatomical suitability (area under the curve of 0.908, p < 0.0001). The mitral inter‐commissural (IC) dimension was best predictive of annular dimensions being within range, with dimensions 50 mm resulting in a negative predictive value of 94.4%.
Conclusions
MSCT‐derived mitral IC dimension and LVESD easily performed measures that are effective predictors of anatomical suitability or screen failure for this tether‐based TMVI device.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- St. Paul's Hospital and University of British Columbia, Vancouver, British Columbia, Canada.
- CHU Bordeaux, Bordeaux, France.
- Royal Brompton Hospital, London, UK.
- University Hospital of Zürich, Zürich, Switzerland.
- Clinique Pasteur, Toulouse, France.
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
ORCID profiles: Alison Duncan
Cite
APA
Blanke, P., Modine, T., Duncan, A., Taramasso, M., Dumonteil, N., Chuang, M. L., & Conradi, L. (2023). Anatomic suitability for transapical transcatheter mitral valve implantation using a tether‐based device. Catheterization and Cardiovascular Interventions, 102(2), 318-327. https://doi.org/10.1002/ccd.30752
Vancouver
Blanke P, Modine T, Duncan A, Taramasso M, Dumonteil N, Chuang ML, et al. Anatomic suitability for transapical transcatheter mitral valve implantation using a tether‐based device. Catheterization and Cardiovascular Interventions. 2023;102(2):318-327. doi:10.1002/ccd.30752
BibTeX
@article{Blanke2023,
author = {Blanke, Philipp and Modine, Thomas and Duncan, Alison and Taramasso, Maurizio and Dumonteil, Nicolas and Chuang, Michael L and Conradi, Lenard},
title = {Anatomic suitability for transapical transcatheter mitral valve implantation using a tether‐based device},
journal = {Catheterization and Cardiovascular Interventions},
year = {2023},
volume = {102},
number = {2},
pages = {318--327},
doi = {10.1002/ccd.30752}
}
EUVIMED